Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
about
Measles epidemic from failure to immunizeNeutralizing antibody response and SARS severityHuman parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review.Sex-specific differences in mortality after high-titre measles immunization in rural Senegal.Reduced childhood mortality after standard measles vaccination at 4-8 months compared with 9-11 months of ageMeasles control in developing and developed countries: the case for a two-dose policy.Measles control in the United States: problems of the past and challenges for the futureEvidence that measles virus hemagglutinin initiates modulation of leukocyte function-associated antigen 1 expressionLong-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-up.Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of ageMeasles among under-9-month-olds in rural Bangladesh: its significance for age at immunization.Two-dose measles vaccination schedulesHuman HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion proteinProtective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infantsGeneration of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.Calibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200.Reflections of a Vaccinologist: Lessons Learned About What We Can Do to Improve Trust in Vaccines and Vaccine Programsa.Measles vaccination policy.A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.Childhood immunisation in the new decade.Persistence of vaccine-induced measles antibody beyond age 12 months: a comparison of response to one and two doses of Edmonston-Zagreb measles vaccine among HIV-infected and uninfected children in Malawi.Comparison of a commercial enzyme immunoassay with plaque reduction neutralization for maternal and infant measles antibody measurement.
P2860
Q24515244-B85EA1CE-70DF-4921-B4BA-42598BF57C51Q28385241-E1EC603F-216A-4DD4-AF05-AFAD90E6AE1DQ33808578-E8C9B941-66E0-41BB-BBE1-F2A6F6E6367DQ33982860-06257AA6-0E11-4392-8756-125F3777D6E6Q34325187-2159B762-E47A-4E05-A0F8-C67A0FBDDC24Q34346137-9406B774-3C15-413D-8899-0BF302EB902DQ34730474-894F1003-5B42-4283-BF9D-CF1130CAC97EQ35366326-16BFE347-4F27-4C7B-A766-5AFC495C3ECFQ35841633-92852906-462C-4519-BC53-D2347C189EFAQ36504062-CC65E9A5-8757-4B9D-B295-0D176002D62CQ36547324-D4E2B5F3-3980-487E-AA74-A8DCFF67CF48Q36669009-A37D75D9-0CA4-4C32-84D4-E051FEC00BCEQ36669791-D289E39E-2745-4508-B6A1-D3733B8CD47DQ36686798-7850EDE8-2AC8-4FC3-8DFD-3EC005B5ED8BQ36818026-4A102766-83AA-4CA4-8325-2C73849FAAF1Q37008134-E3B1A6FD-834B-47F5-BA2B-282D1A44DC04Q37069798-74C023DB-066A-417E-858E-1C46D879730CQ37563593-19A8F22C-7F01-4BE8-89E9-36DA050B4A96Q38649736-108E974C-3D84-4F70-A888-D2B61361ED82Q40964995-D337CF96-A6F9-4E15-BDC8-29BD3702BED5Q41933011-5967BD6C-B217-48B9-BFB7-0BCC3540AD93Q43165119-60FA141C-0762-4B24-9AE3-52699AE74F0EQ46535654-0CE32A02-EAAB-4A2F-B465-8D5416291C6CQ57714344-C85C26E0-B937-4ABF-BCC1-1C5E9DA35D38
P2860
Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwarz measles vaccines.
description
1990 nî lūn-bûn
@nan
1990 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի մարտին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Immunization of six-month-old ...... and Schwarz measles vaccines.
@ast
Immunization of six-month-old ...... and Schwarz measles vaccines.
@en
Immunization of six-month-old ...... and Schwarz measles vaccines.
@nl
type
label
Immunization of six-month-old ...... and Schwarz measles vaccines.
@ast
Immunization of six-month-old ...... and Schwarz measles vaccines.
@en
Immunization of six-month-old ...... and Schwarz measles vaccines.
@nl
prefLabel
Immunization of six-month-old ...... and Schwarz measles vaccines.
@ast
Immunization of six-month-old ...... and Schwarz measles vaccines.
@en
Immunization of six-month-old ...... and Schwarz measles vaccines.
@nl
P2093
P1476
Immunization of six-month-old ...... and Schwarz measles vaccines.
@en
P2093
Albrecht P
Bernier RH
Diaz-Ortega JL
Markowitz LE
Sepulveda J
Valdespino JL
P304
P356
10.1056/NEJM199003013220903
P407
P577
1990-03-01T00:00:00Z